Vinporal 5 mg 20 tablets

Tradename:

Vinporal

Vinporal

Compound:

Each tablet contains:

Vinpocetine 5 mg

Auxiliary components:

lactose, low molecular weight cellulose, talc, magnesium stearate.

Properties:

A drug that improves cerebral circulation. It has a vasodilating, antihypoxic and antiaggregant effect. The mechanism of action is associated with the inhibition of phosphodiesterase, which leads to an increase in the content of cAMP in the cells, which, in turn, causes a decrease in the calcium content in the cytoplasm of smooth muscle cells and relaxation of myofibrils.

It improves metabolism in tissues and dilates the vessels of the brain, increases blood flow, mainly in ischemic areas, improves the supply of oxygen to the brain. Promotes the utilization of glucose and increases the level of catecholamines in the central nervous system, stimulates the metabolism of norepinephrine and serotonin in brain tissues. It reduces platelet aggregation, blood viscosity, increases the deformability of erythrocytes and normalizes venous outflow against the background of a decrease in the resistance of cerebral vessels. Systemic blood pressure drops slightly.

Vinpocetine is effective in the acute period of a stroke: it accelerates the regression of cerebral and focal neurological symptoms, improves memory, attention, and intellectual productivity. In the elderly and senile age, the sensitivity of cerebral vessels to the relaxing effect of vinpocetine increases, which is due to the sensitization of the adenylate cyclase-cAMP system during aging.

Indications:

acute (if parenteral administration is impossible) and chronic forms of cerebrovascular insufficiency (including acute and residual stages of stroke, transient ischemic attacks, encephalopathy, dementia after cerebrovascular accidents);

vascular diseases of the retina and / or choroid (due to atherosclerosis, angiospasm, thrombosis); degenerative changes in the macula caused by atherosclerosis or angiospasm; secondary glaucoma (due to vascular obstruction);

age-related vascular or toxic (drug) hearing impairment, Meniere’s disease, dizziness of labyrinthine origin;

vegetative manifestations of climacteric syndrome.

Dosage and administration:

The drug should be prescribed 5-10 mg 3 times / day for 2 months. Before discontinuing the drug, the dose should be gradually reduced.

Repeated courses are possible 2-3 times a year.

Contraindications:

– severe cardiac arrhythmias;

-IHD (severe course);

– acute stage of hemorrhagic stroke;

-pregnancy;

– lactation (breastfeeding);

-increased sensitivity to the drug.

Precautionary measures:

Vinpocetine is contraindicated for use during pregnancy and lactation (breastfeeding).

Side effects:

From the side of the cardiovascular system: lowering blood pressure, tachycardia, extrasystole, slowing intraventricular conduction.

Storage method:

At a temperature not higher than 30 degrees.

Package:

The cardboard box contains 2 blisters of 10 tablets.